HUTCHMED (China) Ltd Files June 2024 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Jun 7, 2024 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K
TL;DR
HUTCHMED filed its June 6-K, confirming 20-F annual report filings.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on June 7, 2024. This report is for the month of June 2024 and indicates the company files annual reports under Form 20-F. The company's principal executive offices are located in Hong Kong.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding HUTCHMED's reporting status and corporate information.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Filer
- 001-37710 (dollar_amount) — Commission File Number
- 20240607 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the company has made or is required to make public in its home country.
Which form does HUTCHMED (China) Limited use for its annual reports?
HUTCHMED (China) Limited indicates it files annual reports under cover of Form 20-F.
What is the Commission File Number for HUTCHMED (China) Limited?
The Commission File Number for HUTCHMED (China) Limited is 001-37710.
Where are HUTCHMED (China) Limited's principal executive offices located?
The principal executive offices of HUTCHMED (China) Limited are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
What period does this Form 6-K report cover?
This Form 6-K report is filed for the month of June 2024.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 13.7 · Accepted 2024-06-07 06:25:35
Filing Documents
- hcm-20240607x6k.htm (6-K) — 20KB
- hcm-20240607xex99d1.htm (EX-99.1) — 19KB
- hcm-20240607xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000052.txt ( ) — 45KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to initiation of Phase I trial of menin inhibitor HMPL-506 in patients with hematological malignancies in China 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: June 7, 2024 3